TREA

90124014 - NEW ENGLAND BIOLABS, INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE

Follow

Information

  • Trademark
  • 90124014
  • Serial Number
    90124014
  • Registration Number
    6656104
  • Filing Date
    August 19, 2020
    4 years ago
  • Registration Date
    March 01, 2022
    2 years ago
  • Transaction Date
    October 05, 2023
    a year ago
  • Status Date
    March 01, 2022
    2 years ago
  • Published for Opposition Date
    December 14, 2021
    3 years ago
  • Location Date
    March 01, 2022
    2 years ago
  • First Use Anywhere Date
    December 31, 2016
    8 years ago
  • First Use In Commerce Date
    December 31, 2016
    8 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BERNS, LEE ANNE
  • Attorney Docket Number
    NEB-T141-US
    Attorney Name
    Joseph W. Secondine, Jr.
    Law Office Assigned Location Code
    M90
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
NEW ENGLAND BIOLABS, INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE
Case File Statements
  • DM0000: The mark consists of the trade dress design appearing on product packaging consisting of a three-dimensional configuration of a box. The box has four sides, a top, and a bottom. The broken lines depicting the edges and shape of the box indicate placement of the mark on the goods and are not part of the mark. The sides of the box each show the claimed portions of the mark featuring a design consisting of a portion of a butterfly. The long front side of the box also contains the words "New England Biolabs, Inc". shown situated next to a smaller resting butterfly positioned above the letter "B" in "BIOLABS", with the butterfly shown in side profile. The top of the box contains the words "be INSPIRED drive DISCOVERY stay GENUINE" separated by vertical lines.
  • GS0011: Reagents for scientific research use; Reagents for molecular biology and cell biology for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Reagents for diagnostic tests and diagnostic devices for scientific or laboratory purposes, or for in vitro diagnostic processes, or for manufacture of biological reagents, or in vitro diagnostic purposes, all excluding medical or veterinary use; Reagents for genetic research, clinical or medical laboratory use; Reagents for detecting mutations for clinical or medical laboratory use; Reagents for transfer of nucleic acids into cells for laboratory use, research use, or diagnostic use, namely, diagnostic processes for manufacture of biological reagents not for medical or veterinary use; Nucleic acid amplification reagents for scientific, research, laboratory or in vitro diagnostic use; Nucleic acid sequencing reagents for scientific, research, laboratory or in vitro diagnostic use; RNA reverse transcription reagents for scientific, research, laboratory or in vitro diagnostic use; Nucleic acid cleavage reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid synthesis reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid ligation reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cloning reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid fragment assembly reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid binding reagents for scientific, research, laboratory or in vitro diagnostic use; Nucleic acid purification substrates for scientific, research, laboratory or in vitro diagnostic use; Genome editing reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Glycobiology reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Buffer reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acids for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Oligonucleotides for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleotides for scientific, research, laboratory or in vitro diagnostic use; Cells for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Molecular tags for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Dyes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Magnetic beads comprised primarily of iron oxides, for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; DNA Adapters for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid purification substrates for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Storage reagents being reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; DNA molecular weight markers; Plasmids for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Molecular size markers for use in molecular biology for determining the size of molecules for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Cells for use in molecular biology for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Prokaryotic cells for cloning for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Enzyme reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Enzymes for scientific and research use; Enzymes for diagnostic use, namely, enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Enzymes for molecular biology and cell biology applications, namely, for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Chemicals and biochemicals in the nature of enzymes for the manufacture of vaccines and pharmaceuticals; Kits for scientific and research use comprising enzymes; Kits for in vitro diagnostic use comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cloning kits comprising a cloning enzyme or plasmid for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid amplification kits comprising an amplification enzyme for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid sequencing kits comprising a sequencing enzyme for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; RNA reverse transcription kits comprising a reverse transcriptase for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cleavage kits comprising cleavage enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use, not for medical or veterinary use; Nucleic acid synthesis kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid ligation kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cloning kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Genome editing kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid fragment assembly kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid binding kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Glycobiology kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Kits containing buffer reagents, nucleic acids, nucleotides, cells, molecular tags, dyes, nucleic acid purification substrates, enzymes, storage reagents, DNA molecular weight markers, and DNA plasmids for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use
  • D10000: "NEW ENGLAND", "BIOLABS" AND "INC."
Case File Event Statements
  • 10/4/2023 - a year ago
    36 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 3/1/2022 - 2 years ago
    35 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/14/2021 - 3 years ago
    34 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/14/2021 - 3 years ago
    33 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/24/2021 - 3 years ago
    32 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/7/2021 - 3 years ago
    31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/7/2021 - 3 years ago
    30 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/7/2021 - 3 years ago
    29 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/7/2021 - 3 years ago
    28 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/7/2021 - 3 years ago
    27 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/7/2021 - 3 years ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/7/2021 - 3 years ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/7/2021 - 3 years ago
    24 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/4/2021 - 3 years ago
    23 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 10/4/2021 - 3 years ago
    22 - PRIORITY ACTION E-MAILED Type: GPRA
  • 10/4/2021 - 3 years ago
    21 - PRIORITY ACTION WRITTEN Type: CPRA
  • 9/23/2021 - 3 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/23/2021 - 3 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/23/2021 - 3 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/23/2021 - 3 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/26/2021 - 3 years ago
    16 - PETITION TO DIRECTOR GRANTED Type: PCGR
  • 8/12/2021 - 3 years ago
    15 - ASSIGNED TO PETITION STAFF Type: APET
  • 4/15/2021 - 3 years ago
    14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/15/2021 - 3 years ago
    13 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/15/2021 - 3 years ago
    12 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/8/2021 - 3 years ago
    11 - TEAS PETITION TO DIRECTOR RECEIVED Type: TPDR
  • 3/15/2021 - 3 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/15/2021 - 3 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/15/2021 - 3 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/24/2020 - 4 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/24/2020 - 4 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/24/2020 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/22/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/22/2020 - 4 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 9/20/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/22/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP